Cancer stages describe how large a tumor is and how far it has spread in the body. Most solid cancers are classified into five stages, numbered 0 through IV, with higher numbers indicating more extensive spread. Staging is one of the most important factors in determining treatment options and predicting outcomes.
Stages 0 Through IV
Stage 0 refers to abnormal cells that haven’t spread beyond where they first formed. This is sometimes called “carcinoma in situ” or a precancerous stage. The cells are contained in their original layer of tissue and haven’t invaded deeper structures.
Stage I means a small tumor confined to one area. It hasn’t reached nearby lymph nodes or other parts of the body. Along with stage 0, this is what doctors consider early-stage cancer, and it typically has the most favorable outlook.
Stage II indicates a larger tumor that may have spread to nearby lymph nodes but hasn’t traveled to distant organs. Stage III means the tumor has grown deeper into surrounding tissues and has potentially spread to more lymph nodes in the region. These are sometimes grouped together as “locally advanced” cancer.
Stage IV is metastatic cancer. The disease has spread from its original site to distant organs or areas of the body. A breast cancer that reaches the bones or lungs, for example, would be stage IV.
How Staging Affects Survival
The gap in outcomes between early and late stages can be dramatic. Lung cancer illustrates this clearly: when caught while still localized, the five-year relative survival rate is 65.5%. Once it spreads to regional lymph nodes, that drops to 38.2%. At the distant (metastatic) stage, it falls to 10.5%. These numbers come from the National Cancer Institute’s SEER database covering 2016 through 2022. Other cancer types show the same general pattern, though the specific percentages vary widely.
This is why screening programs exist for cancers like breast, lung, cervical, and colon cancer. Catching cancer at a lower stage fundamentally changes what treatment can accomplish.
The TNM System Behind the Numbers
The stage number you hear from your doctor is actually derived from a more detailed classification called the TNM system. Each letter captures a different dimension of the cancer’s spread:
- T (Tumor): The size and extent of the primary tumor. T1 is smaller, while T3 or T4 means the tumor is larger or has grown into nearby tissues.
- N (Nodes): Whether cancer has reached nearby lymph nodes, and how many. N0 means no lymph node involvement. N1, N2, or N3 reflects increasing numbers or locations of affected nodes.
- M (Metastasis): Whether cancer has spread to distant parts of the body. M0 means it hasn’t. M1 means it has.
Doctors combine these three categories to assign the overall stage number. A tumor that is T2, N0, M0 might be stage II for one cancer type but stage I for another. The exact groupings vary by cancer because the biology of each type behaves differently.
Stage vs. Grade
Stage and grade are easily confused, but they measure different things. Stage tells you how far the cancer has spread. Grade tells you how aggressive the cancer cells themselves appear under a microscope.
Pathologists compare cancer cells to normal, healthy cells. If the cancer cells still look relatively organized and similar to normal tissue, that’s a low-grade (well-differentiated) tumor. These tend to grow more slowly. If the cells look highly abnormal and disorganized, that’s a high-grade (poorly differentiated) tumor, which typically grows and spreads faster. Both stage and grade factor into treatment decisions and prognosis, but they answer fundamentally different questions.
How Doctors Determine Your Stage
Staging usually happens at diagnosis, before treatment begins. This initial assessment is called the clinical stage. It draws on physical exams, imaging, biopsies, and sometimes blood tests. The specific imaging tools depend on the cancer type. Lung cancers are typically staged with CT scans and PET scans. Breast cancers rely on mammography, ultrasound, and sometimes MRI along with sentinel lymph node procedures. Prostate cancers may use ultrasound-guided biopsy and bone scans.
If surgery is the first treatment, doctors can also assign a pathological stage based on what they learn during the operation and from examining the removed tissue. Pathological staging tends to be more precise because the surgeon and pathologist can directly see how far the cancer has grown. In medical records, you might see a lowercase “c” for clinical stage (like cT1) or a “p” for pathological stage (like pN2).
One important detail: the stage assigned at diagnosis generally doesn’t change, even if the cancer later progresses or responds to treatment. If someone is diagnosed at stage II and the cancer later spreads, doctors may describe a recurrence or progression, but the original stage typically stays on record.
Blood Cancers Use Different Systems
The TNM system works for solid tumors, where you can measure a physical mass and track its spread to lymph nodes and distant organs. Blood cancers like leukemia and lymphoma don’t form tumors the same way, so they need different approaches.
Lymphomas use the Lugano classification, an updated version of the older Ann Arbor system. It tracks how many lymph node regions are involved and whether the disease has crossed the diaphragm (the muscle separating the chest from the abdomen) or reached organs outside the lymphatic system.
Chronic lymphocytic leukemia uses the Rai staging system, which looks at factors like lymph node swelling, enlargement of the spleen or liver, low red blood cell counts, and low platelet counts. Each of these reflects how extensively the leukemia is affecting the body’s normal blood cell production.
What Staging Means for Treatment
Early-stage cancers (stages I and II) are typically localized, which means the primary goal is to eliminate the cancer completely. Surgery, radiation, or a combination of both can often target the tumor directly. For many stage I cancers, surgery alone may be sufficient.
As the stage increases, treatment usually becomes more systemic, meaning it travels through the bloodstream to reach cancer cells that may have spread beyond the original site. These therapies can destroy cancer cells that are too spread out to remove surgically, or catch cells that localized treatments might miss.
At stage IV, treatment goals often shift. Complete elimination of the cancer may not be possible, so the focus moves toward slowing progression, shrinking tumors, and managing symptoms to maintain quality of life. That said, some stage IV cancers respond well to treatment, and the line between “treatable” and “curable” continues to evolve depending on the specific cancer type and its molecular characteristics.